PVLA 8-K 2026-08-04

PALVELLA THERAPEUTICS, INC. (PVLA) 8-K dated 2026-08-04 — accession 0001193125-26-331556. This URL is the filing, not the PVLA hub.

PALVELLA THERAPEUTICS, INC. (PVLA) is a biotechnology company listed on NASDAQ.

PALVELLA THERAPEUTICS, INC. filed a 8-K on 2026-08-04. Accession 0001193125-26-331556.

Cached items: 2.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported PVLA revenue for 2023-12-31 was $42.8M. Net income was -$24.5M. Revenue was up 65.3% from 2022-12-31 to 2023-12-31. PVLA currently screens at market cap $1.64B.

Not investment advice. The PVLA SEC hub lists recent forms. The stock page is the research view.